Form 8-K - Current report:
SEC Accession No. 0001193125-13-199132
Filing Date
2013-05-03
Accepted
2013-05-03 16:11:56
Documents
6
Period of Report
2013-05-03
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d530916d8k.htm 8-K 26418
2 EX-10.78 d530916dex1078.htm EX-10.78 70800
3 EX-10.79 d530916dex1079.htm EX-10.79 62169
4 EX-10.80 d530916dex1080.htm EX-10.80 16519
5 EX-99.1 d530916dex991.htm EX-99.1 9573
6 GRAPHIC g530916g08t18.jpg GRAPHIC 25915
  Complete submission text file 0001193125-13-199132.txt   222630
Mailing Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710
Business Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710 5108485100
DYNAVAX TECHNOLOGIES CORP (Filer) CIK: 0001029142 (see all company filings)

EIN.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34207 | Film No.: 13812775
SIC: 2834 Pharmaceutical Preparations